Dalan Rinkoo, Leow Melvin Khee-Shing, Ng David Chee-Eng
Department of Endocrinology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433.
Ann Clin Biochem. 2008 Nov;45(Pt 6):612-5. doi: 10.1258/acb.2008.008098.
Factors determining the responsiveness to antithyroid drugs (ATDs) in Graves' disease are not fully known. Notwithstanding the typical pattern and tempo of thyroid hormone responses to thionamides, the existence of an unusual subset of Graves' disease with extraordinarily rapid thyroid hormone responses to ATDs will prove challenging even to the expert clinician. Termed 'rapid responder Graves' disease' or 'high turnover Graves' disease', the serum thyroxine (FT4) and triiodothyronine (FT3) of patients with this variant of thyrotoxicosis can decline precipitously during the initiation of ATDs and yet escalate acutely upon discontinuation of pharmacological intervention. We describe a case that presented with low serum FT4 and FT3 in association with suppressed serum thyrotropin (TSH) concentrations soon after starting carbimazole even at a low dose. The erratic clinical course comprising largely of serum FT4 nadirs and peaks is elaborated to facilitate appreciation of the difficulty in the stabilization of the thyroid with ATDs. The possible pathogenetic mechanisms for the chaotic fluctuations in thyroid hormones to minor changes in thionamide dose adjustments are discussed as well.
Graves病中决定对抗甲状腺药物(ATD)反应性的因素尚不完全清楚。尽管甲状腺激素对硫代酰胺的反应有典型模式和节奏,但存在一类不寻常的Graves病患者亚群,他们对ATD的甲状腺激素反应异常迅速,这对专业临床医生来说也是一项挑战。这种甲状腺毒症变体患者被称为“快速反应型Graves病”或“高代谢型Graves病”,在开始使用ATD时,其血清甲状腺素(FT4)和三碘甲状腺原氨酸(FT3)会急剧下降,但在停止药物干预后又会急剧上升。我们描述了一例患者,在开始使用低剂量卡比马唑后不久,血清FT4和FT3降低,同时血清促甲状腺素(TSH)浓度受到抑制。详细阐述了主要由血清FT4最低点和峰值组成的不稳定临床过程,以帮助理解使用ATD稳定甲状腺功能的困难。还讨论了甲状腺激素随硫代酰胺剂量微小变化而出现混乱波动的可能发病机制。